Cargando…
HbA(1C) as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters
BACKGROUND AND AIMS: Multiple non-invasive methods including radiological, anthropometric and biochemical markers have been reported with variable performance. The present study assessed glycosylated hemoglobin (HbA(1C)) as a biomarker to predict non-alcoholic fatty liver disease (NAFLD) and its sev...
Autores principales: | Masroor, Muhammad, Haque, Zeba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868696/ https://www.ncbi.nlm.nih.gov/pubmed/33604251 http://dx.doi.org/10.14218/JCTH.2019.00046 |
Ejemplares similares
-
HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels
por: Chen, Changxi, et al.
Publicado: (2020) -
Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population
por: Ma, Han, et al.
Publicado: (2013) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017) -
Is HbA1c an ideal biomarker of well-controlled diabetes?
por: Kaiafa, Georgia, et al.
Publicado: (2020) -
HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)